X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19161) 19161
Publication (1765) 1765
Book Review (272) 272
Book / eBook (116) 116
Magazine Article (79) 79
Book Chapter (35) 35
Conference Proceeding (19) 19
Government Document (8) 8
Newspaper Article (5) 5
Web Resource (3) 3
Dissertation (2) 2
Newsletter (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17131) 17131
female (14742) 14742
index medicus (7607) 7607
oncology (7495) 7495
middle aged (6870) 6870
breast neoplasms - drug therapy (6519) 6519
breast cancer (5750) 5750
adult (5126) 5126
animals (5056) 5056
cancer (4727) 4727
aged (4696) 4696
breast-cancer (4143) 4143
breast neoplasms - chemically induced (3209) 3209
male (2975) 2975
risk factors (2958) 2958
breast neoplasms - pathology (2860) 2860
chemotherapy (2703) 2703
antineoplastic agents - adverse effects (2060) 2060
mice (2033) 2033
antineoplastic combined chemotherapy protocols - adverse effects (1889) 1889
research (1845) 1845
rats (1758) 1758
risk (1675) 1675
care and treatment (1639) 1639
cell line, tumor (1601) 1601
antineoplastic combined chemotherapy protocols - therapeutic use (1597) 1597
health aspects (1557) 1557
tumors (1493) 1493
neoplasms - drug therapy (1470) 1470
treatment outcome (1404) 1404
therapy (1397) 1397
pharmacology & pharmacy (1361) 1361
apoptosis (1285) 1285
breast neoplasms - metabolism (1263) 1263
antineoplastic agents - therapeutic use (1256) 1256
medicine & public health (1248) 1248
expression (1222) 1222
time factors (1211) 1211
metastasis (1197) 1197
women (1184) 1184
tamoxifen - adverse effects (1171) 1171
analysis (1160) 1160
article (1141) 1141
postmenopausal women (1140) 1140
tamoxifen (1130) 1130
breast neoplasms - epidemiology (1101) 1101
aged, 80 and over (1059) 1059
biochemistry & molecular biology (1040) 1040
dose-response relationship, drug (1033) 1033
breast neoplasms - genetics (981) 981
prevention (977) 977
obstetrics & gynecology (936) 936
estrogen (931) 931
mammary neoplasms, experimental - chemically induced (916) 916
cell biology (888) 888
neutropenia - chemically induced (886) 886
carcinoma (883) 883
medicine, general & internal (873) 873
drug administration schedule (861) 861
estrogen replacement therapy - adverse effects (857) 857
menopause (815) 815
prospective studies (798) 798
tamoxifen - therapeutic use (789) 789
antineoplastic agents, hormonal - adverse effects (785) 785
gene expression (785) 785
prognosis (778) 778
neoplasm metastasis (772) 772
breast (771) 771
incidence (767) 767
proteins (763) 763
carcinogenesis (756) 756
drug therapy (747) 747
pregnancy (746) 746
research article (739) 739
growth (737) 737
rats, sprague-dawley (731) 731
follow-up studies (730) 730
retrospective studies (724) 724
antineoplastic agents - pharmacology (722) 722
risk assessment (722) 722
chemotherapy, adjuvant (705) 705
oncology, experimental (688) 688
development and progression (687) 687
case-control studies (683) 683
cells (683) 683
cyclophosphamide - administration & dosage (670) 670
breast neoplasms - prevention & control (667) 667
genetic aspects (658) 658
medicine (652) 652
breast neoplasms - surgery (632) 632
cancer therapies (624) 624
cancer research (618) 618
endometrial neoplasms - chemically induced (613) 613
apoptosis - drug effects (609) 609
in-vitro (609) 609
antineoplastic agents - administration & dosage (607) 607
doxorubicin - administration & dosage (598) 598
toxicology (594) 594
cell proliferation - drug effects (593) 593
trastuzumab (591) 591
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (98) 98
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Online Resources - Online (3) 3
Humber River Regional Hospital - Finch Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Markham Stouffville Hospital - Stacks (2) 2
Mt Sinai Hospital - Pathology (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Credit Valley Hospital - Reference (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Reference (1) 1
New College (Ivey) - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Scarborough Hospital - General (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18081) 18081
German (269) 269
French (240) 240
Japanese (238) 238
Chinese (87) 87
Spanish (78) 78
Russian (68) 68
Italian (56) 56
Dutch (51) 51
Polish (34) 34
Danish (31) 31
Portuguese (26) 26
Norwegian (25) 25
Swedish (21) 21
Czech (16) 16
Finnish (15) 15
Hungarian (11) 11
Hebrew (10) 10
Bulgarian (5) 5
Serbian (4) 4
Croatian (2) 2
Romanian (2) 2
Bosnian (1) 1
Korean (1) 1
Lithuanian (1) 1
Slovak (1) 1
Slovenian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 2011, Volume 103, Issue 17, pp. 1299 - 1309
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 7, pp. 627 - 636
Journal Article
Cancer Prevention Research, ISSN 1940-6207, 06/2010, Volume 3, Issue 6, pp. 696 - 706
The selective estrogen-receptor modulator (SERM) tamoxifen became the first U. S. Food and Drug Administration (FDA)-approved agent for reducing breast cancer... 
WOMEN | RISK-FACTORS | ONCOLOGY | ESTROGEN | FOLLOW-UP | OUTCOMES | MUTATIONS | NSABP | Uterus - pathology | Raloxifene Hydrochloride - adverse effects | Raloxifene Hydrochloride - pharmacology | Adenocarcinoma - pathology | Raloxifene Hydrochloride - therapeutic use | Cataract - chemically induced | Follow-Up Studies | Thromboembolism - chemically induced | Fractures, Spontaneous - epidemiology | Estrogens | Humans | Middle Aged | Osteoporosis, Postmenopausal - complications | Endometrial Neoplasms - chemically induced | Selective Estrogen Receptor Modulators - adverse effects | Risk | Cataract - epidemiology | Thromboembolism - epidemiology | Drug Utilization | Incidence | Selective Estrogen Receptor Modulators - therapeutic use | Aged, 80 and over | Adult | Female | Osteoporosis, Postmenopausal - prevention & control | Breast Neoplasms - epidemiology | Myocardial Ischemia - epidemiology | Neoplasms, Hormone-Dependent - prevention & control | Double-Blind Method | Neoplasm Invasiveness | Myocardial Ischemia - prevention & control | Fractures, Spontaneous - etiology | Endometrial Neoplasms - epidemiology | Neoplasms, Hormone-Dependent - epidemiology | Breast Neoplasms - prevention & control | Adenocarcinoma - prevention & control | Fractures, Spontaneous - prevention & control | Breast Neoplasms - pathology | Neoplasms, Hormone-Dependent - pathology | Tamoxifen - therapeutic use | Tamoxifen - pharmacology | Aged | Tamoxifen - adverse effects | Adenocarcinoma - epidemiology | Selective Estrogen Receptor Modulators - pharmacology | Index Medicus
Journal Article
Journal Article
Nature, ISSN 0028-0836, 02/2012, Volume 482, Issue 7385, pp. 400 - 404
Journal Article
European Journal of Cancer, ISSN 0959-8049, 10/2017, Volume 84, pp. 60 - 68
Journal Article
Journal Article
Journal Article